Presentation ACC 2022 5-Year Incidence, Outcomes and Predictors of Structural Valve Deterioration of Transcatheter and Surgical Aortic Bioprostheses: Insights from the CoreValve US Pivotal and SURTAVI Trials Presenter: Michael J. Reardon April 04, 2022
Presentation ACC 2019 Primary Results From the Evolut Low Risk Trial Presenter: Michael J. Reardon March 17, 2019
Presentation ACC 2017 First Results from the SURTAVI Clinical Trial Presenter: Michael J. Reardon March 17, 2017
Presentation ACC 2015 A Randomized Comparison of Self-expanding Transcatheter and Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis Deemed at Increased Risk for Surgery 2-Year Outcomes Presenter: Michael J. Reardon March 15, 2015